GPCRs

GPCRs in cancer: New therapeutic opportunities

  • Chair(s):

    Paul Insel
    University of California San Diego The United States of America

  • Session description:

    GPCRs in Cancer: Unknown unknowns waiting to be discovered
    Professor Paul Insel
    University of California, San Diego, The United States of America

    Protease-activated receptors in cancer
    Professor Rachel Bar-Shavit
    Professor, Hebrew University School of Medicine, Hadassah Medical Center, Jerusalem, Israel

    Oral communication speaker - to be confirmed in 2022.

    Viral GPCRs: Modulators of cancer
    Professor Martine Smit
    Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

    G protein-coupled estrogen receptor (GPER/GPR30): A mediator of estrogen action in breast cancer
    Dr Rosamaria Lappano
    University of Calabria, Calabria, Italy

  • Sponsored by:

    the British Journal of Pharmacology

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Tags:

Date

06 Jul 2023

Time

9:45 am - 12:10 pm

Speakers

Leave A Comment